JRS PHARMA announced the JRS PHARMA & Gujarat Microwax GMW 4 Manufacturing facility in Gujarat, India, was awarded an EXCiPACT™ Certificate for Good Manufacturing Practices (GMP). With this facility's certification, all of JRS PHARMA's EMCOCEL® (Microcrystalline Cellulose) production sites are EXCiPACT GMP certified, providing a robust and secure supply chain.
This document demonstrates that the JRS PHARMA & Gujarat Microwax Pvt. Ltd. GMW 4 Manufacturing facility operates according to the EXCiPACT Good Manufacturing Practice (GMP). The certificate helps drug manufacturers reduce efforts and costs as they need to either perform audits of new suppliers or commission 3rd party physical audits to demonstrate GMP compliance. With the institution of new travel restrictions due to COVID-19, EXCiPACT certificates offer customers risk assessment assurance without the need to travel.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
JRS PHARMA's line of Microcrystalline Cellulose products produced at the Gujarat facility includes EMCOCEL®, the premium tablet binder designed for specific formulation needs. EMCOCEL® MCC is an odorless, tasteless, white powder with a high degree of brightness, derived from highly purified wood pulp. With a wide range of product grades, EMCOCEL® offers high chemical purity, along with technical and economic benefits for multiple applications.